Mario Gabelli Abbott Laboratories Transaction History

Gamco Investors, Inc. Et Al

$8.37 Billion
Q1 2025

A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Abbott Laboratories stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 22,135 shares of ABT stock, worth $2.96 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,135

Previous 22,230 0.43%

Holding current value

$2.96 Million

Previous $2.51 Million 16.79%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$111.1 - $140.22 $10,554 - $13,320	-95 Reduced 0.43%	22,135 $2.94 Million
Q4 2024 Feb 13, 2025	SELL	$111.93 - $119.39 $38,056 - $40,592	-340 Reduced 1.51%	22,230 $2.51 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $38,727 - $45,716	-387 Reduced 1.69%	22,570 $2.57 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $6,648 - $7,421	-66 Reduced 0.29%	22,957 $2.39 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $68,011 - $75,116	-621 Reduced 2.63%	23,023 $2.62 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $6,400 - $7,679	-67 Reduced 0.28%	23,644 $2.29 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $341,039 - $379,989	-3,384 Reduced 12.49%	23,711 $2.58 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $7,070 - $8,322	-73 Reduced 0.27%	27,095 $2.74 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $316,074 - $370,804	3,325 Added 13.95%	27,168 $2.98 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $21,287 - $24,646	220 Added 0.93%	23,843 $2.31 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $18,066 - $21,836	-177 Reduced 0.74%	23,623 $2.57 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $190,641 - $232,474	-1,672 Reduced 6.56%	23,800 $2.82 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $178,147 - $218,131	1,542 Added 6.44%	25,472 $3.59 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2,916 - $3,226	25 Added 0.1%	23,930 $2.83 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $15,445 - $18,181	-146 Reduced 0.61%	23,905 $2.77 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $126,689 - $149,259	-1,164 Reduced 4.62%	24,051 $2.88 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $31,500 - $34,326	-300 Reduced 1.18%	25,215 $2.76 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $35,739 - $43,403	390 Added 1.55%	25,515 $2.78 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $1.38 Million - $1.77 Million	-18,033 Reduced 41.78%	25,125 $2.3 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $962,088 - $1.41 Million	-15,315 Reduced 26.19%	43,158 $3.41 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $6,280 - $6,992	80 Added 0.14%	58,473 $5.08 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $1.18 Million - $1.28 Million	14,384 Added 32.68%	58,393 $4.89 Million
Q2 2019 Aug 02, 2019	SELL	$72.88 - $85.0 $1.32 Million - $1.54 Million	-18,118 Reduced 29.16%	44,009 $3.7 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $362,951 - $438,808	-5,481 Reduced 8.11%	62,127 $4.97 Million
Q4 2018 Jan 30, 2019	BUY	$65.56 - $74.27 $466,656 - $528,653	7,118 Added 11.77%	67,608 $4.89 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $13,074 - $15,772	-215 Reduced 0.35%	60,490 $4.44 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $196,313 - $216,671	-3,410 Reduced 5.32%	60,705 $3.7 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $121,993 - $137,928	-2,168 Reduced 3.27%	64,115 $3.84 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $23,887 - $25,574	-445 Reduced 0.67%	66,283 $3.78 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $3.21 Million - $3.58 Million	66,728	66,728 $3.56 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Mario Gabelli's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Account